| Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management AU Anka, MI Tahir, SD Abubakar, M Alsabbagh, Z Zian, H Hamedifar, ... Scandinavian journal of immunology 93 (4), e12998, 2021 | 344 | 2021 |
| Preparation and physicochemical characterization of naproxen–PLGA nanoparticles Y Javadzadeh, F Ahadi, S Davaran, G Mohammadi, A Sabzevari, ... Colloids and Surfaces B: Biointerfaces 81 (2), 498-502, 2010 | 139 | 2010 |
| Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment R Varshochian, M Riazi‐Esfahani, M Jeddi‐Tehrani, AR Mahmoudi, ... Journal of biomedical materials research part A 103 (10), 3148-3156, 2015 | 111 | 2015 |
| The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments R Varshochian, M Jeddi-Tehrani, AR Mahmoudi, MR Khoshayand, ... European Journal of Pharmaceutical Sciences 50 (3-4), 341-352, 2013 | 100 | 2013 |
| Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies A Sabzevari, K Adibkia, H Hashemi, A Hedayatfar, N Mohsenzadeh, ... European journal of pharmaceutics and biopharmaceutics 84 (1), 63-71, 2013 | 90 | 2013 |
| Physicochemical characterization of naproxen solid dispersions prepared via spray drying technology K Adibkia, M Barzegar-Jalali, H Maheri-Esfanjani, S Ghanbarzadeh, ... Powder technology 246, 448-455, 2013 | 64 | 2013 |
| Free-radical-scavenging principles from Phlomis caucasica A Delazar, A Sabzevari, M Mojarrab, H Nazemiyeh, S Esnaashari, ... Journal of natural medicines 62, 464-466, 2008 | 45 | 2008 |
| The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases SPDG Berry, C Dossou, A Kashif, N Sharifinejad, G Azizi, H Hamedifar, ... International Immunopharmacology 102, 108402, 2022 | 44 | 2022 |
| Safety and immunogenicity of SpikoGen®, an Advax-CpG55. 2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and … P Tabarsi, N Anjidani, R Shahpari, M Mardani, A Sabzvari, B Yazdani, ... Clinical Microbiology and Infection 28 (9), 1263-1271, 2022 | 42 | 2022 |
| Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide A Sabzevari, K Adibkia, H Hashemi, BG De Geest, N Mohsenzadeh, ... Investigative ophthalmology & visual science 54 (8), 5520-5526, 2013 | 37 | 2013 |
| Methylprednisolone acetate–Eudragit® RS100 electrospuns: Preparation and physicochemical characterization N Jafari-Aghdam, K Adibkia, S Payab, M Barzegar-Jalali, A Parvizpur, ... Artificial cells, nanomedicine, and biotechnology 44 (2), 497-503, 2016 | 36 | 2016 |
| Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis FS Rizvi, H Zainaldain, H Rafiemanesh, M Jamee, N Hossein-Khannazer, ... Expert review of clinical immunology 16 (12), 1227-1235, 2020 | 32 | 2020 |
| Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55. 2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized … P Tabarsi, N Anjidani, R Shahpari, M Mardani, A Sabzvari, B Yazdani, ... Clinical Microbiology and Infection 29 (2), 215-220, 2023 | 30 | 2023 |
| Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS‐like diseases: A systematic review N Hafezi, M Zaki‐Dizaji, M Nirouei, G Asadi, N Sharifinejad, M Jamee, ... Pediatric Allergy and Immunology 32 (7), 1519-1532, 2021 | 26 | 2021 |
| Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review N Sharifinejad, M Zaki-Dizaji, S Tebyanian, H Zainaldain, M Jamee, ... Expert Review of Clinical Immunology 17 (8), 807-817, 2021 | 23 | 2021 |
| Gastro retentive drug delivery systems: A review K Adibkia, S Ghanbarzadeh, G Mohammadi, RB Atashgah, A Sabzevari Journal of Reports in Pharmaceutical Sciences 2 (2), 190-204, 2013 | 18 | 2013 |
| Clinical, immunologic and molecular spectrum of patients with immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome: a systematic review F Kiaee, M Zaki-Dizaji, N Hafezi, A Almasi-Hashiani, H Hamedifar, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | 15 | 2021 |
| Inclusion of piroxicam in mesoporous phosphate glass–ceramic and evaluation of the physiochemical characteristics Y Javadzadeh, RB Atashgah, M Barzegar-Jalali, F Soleimani, ... Colloids and Surfaces B: Biointerfaces 116, 751-756, 2014 | 13 | 2014 |
| Approach to genetic diagnosis of inborn errors of immunity through next-generation sequencing E Karimi, F Mahmoudian, SOL Reyes, UA Bargir, M Madkaikar, H Artac, ... Molecular Immunology 137, 57-66, 2021 | 11 | 2021 |
| Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices K Adibkia, S Ghanbarzadeh, G Mohammadi, HZ Khiavi, A Sabzevari, ... Drug research 64 (03), 118-123, 2014 | 7 | 2014 |
